A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
- Resource Type
- Abstract
- Authors
- Yee, Andrew J.; Laubach, Jacob P.; Campagnaro, Erica L. ; Lipe, Brea C.; Nadeem, Omar; Friedman, Robb S; Cole, Craig E.; O'Donnell, Elizabeth K.; Bianchi, Giada; Branagan, Andrew R.; Shapiro, Samantha J. ; Harrington, Cynthia C. ; Burke, Jill N. ; Gammon, Marilyn T. ; Lively, Kathleen J. ; Thorburn, Cassandra A. ; Mann, Mason L. ; Lohr, Jens G.; Anderson, Kenneth C.; Richardson, Paul G.; Raje, Noopur S.
- Source
- In Blood 13 November 2019 134 Supplement 1:3169-3169
- Subject
- Language
- ISSN
- 0006-4971